Povidone-iodine 100 MG/ML Topical Solution [Betadine] — RxCUI 211108
RxNorm drug concept · Semantic branded drug
RxCUI 211108
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
8 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI211108
Official namePovidone-iodine 100 MG/ML Topical Solution [Betadine]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBetadine 10 % Topical Solution; Betadine 100 MG/ML Topical Solution
FDA products mapped2
Package NDCs mapped8
Reported Medicaid activity (SDUD)810 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Povidone-Iodine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's an antiseptic that lowers germs on the skin. Depending on the product, it's used to prep skin before surgery, as a hand scrub or hand wash, or as first aid for minor cuts, scr...
- It goes on the skin, not in your mouth. Swabs are wiped on and thrown away after one use, and scrubs are lathered and rinsed. Follow the directions on your specific product, and do...
- If it gets in your eyes, ears or mouth, rinse with cold water right away and contact a doctor. It can cause serious or permanent injury. If it's swallowed, get medical help or call...
- What if it gets in my eyes or I swallow some?
🕸️ Concept Web — How Povidone-iodine 100 MG/ML Topical Solution [Beta... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Povidone-iodine 100 MG/ML Topical Solution [Betadine]
RxCUI 211108 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Povidone-iodine
8611IN
-
Povidone-iodine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Betadine
202750BN
-
Betadine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Povidone-iodine Topical Solution
374503SCDF -
Povidone-iodine Topical Product
1161091SCDG -
Povidone-iodine Topical Solution [Betadine]
365392SBDF -
Betadine Topical Product
1172236SBDG -
Topical Solution
316986DF -
Topical Product
1151122DFG
-
Povidone-iodine Topical Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Povidone-iodine 100 MG/ML Topical Solution
312564SCD -
Povidone-iodine 100 MG/ML
329044SCDC -
Povidone-iodine 100 MG/ML [Betadine]
571570SBDC
-
Povidone-iodine 100 MG/ML Topical Solution
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Povidone-iodine 100 MG/ML Topical Solution
SCD · 312564 -
Povidone-iodine 100 MG/ML
SCDC · 329044 -
Povidone-iodine Topical Solution
SCDF · 374503 -
Povidone-iodine Topical Product
SCDG · 1161091
Brand-Name Concepts
-
Povidone-iodine 100 MG/ML [Betadine]
SBDC · 571570 -
Povidone-iodine Topical Solution [Betadine]
SBDF · 365392 -
Betadine Topical Product
SBDG · 1172236 -
Betadine
BN · 202750
📦 FDA Products & Package NDCs
2 products · 8 package NDCs
8 package NDCs map to RxCUI 211108 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 67618-0150-01 | 3780 mL in 1 BOTTLE (67618-150-01) | Betadine Solution | Atlantis Consumer Healthcare, Inc. | 1980-06-01 |
| 67618-0150-04 | 118 mL in 1 BOTTLE (67618-150-04) | Betadine Solution | Atlantis Consumer Healthcare, Inc. | 1980-06-01 |
| 67618-0150-05 | 14.8 mL in 1 BOTTLE (67618-150-05) | Betadine Solution | Atlantis Consumer Healthcare, Inc. | 1980-06-01 |
| 67618-0150-08 | 237 mL in 1 BOTTLE (67618-150-08) | Betadine Solution | Atlantis Consumer Healthcare, Inc. | 1980-06-01 |
| 67618-0150-09 | 237 mL in 1 BOTTLE (67618-150-09) | Betadine Solution | Atlantis Consumer Healthcare, Inc. | 1980-06-01 |
| 67618-0150-16 | 2 BOTTLE in 1 PACKAGE (67618-150-16) / 237 mL in 1 BOTTLE | Betadine Solution | Atlantis Consumer Healthcare, Inc. | 2025-06-20 |
| 67618-0150-17 | 473 mL in 1 BOTTLE (67618-150-17) | Betadine Solution | Atlantis Consumer Healthcare, Inc. | 1980-06-01 |
| 67618-0150-18 | 177 mL in 1 BOTTLE (67618-150-18) | Betadine Solution | Atlantis Consumer Healthcare, Inc. | 2020-01-09 |
Observed labelers:
Atlantis Consumer Healthcare, Inc. (8)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.0130
Range $0.0104–$0.0153
· middle 50% $0.0117–$0.0142
· 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.